ChitogenX Inc. (CSE: CHGX)
Canada
· Delayed Price · Currency is CAD
0.0150
-0.0050 (-25.00%)
Jan 17, 2025, 4:00 PM EST
ChitogenX Statistics
Total Valuation
ChitogenX has a market cap or net worth of CAD 1.25 million. The enterprise value is 5.43 million.
Market Cap | 1.25M |
Enterprise Value | 5.43M |
Important Dates
The last earnings date was Friday, December 27, 2024.
Earnings Date | Dec 27, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
ChitogenX has 83.13 million shares outstanding. The number of shares has increased by 43.11% in one year.
Current Share Class | n/a |
Shares Outstanding | 83.13M |
Shares Change (YoY) | +43.11% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 16.85% |
Owned by Institutions (%) | n/a |
Float | 45.34M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -3.50 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.01
Current Ratio | 0.01 |
Quick Ratio | 0.01 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -1.67 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -152.34% |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -83.33% in the last 52 weeks. The beta is -0.75, so ChitogenX's price volatility has been lower than the market average.
Beta (5Y) | -0.75 |
52-Week Price Change | -83.33% |
50-Day Moving Average | 0.01 |
200-Day Moving Average | 0.02 |
Relative Strength Index (RSI) | 49.66 |
Average Volume (20 Days) | 509,968 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -1.33M |
Pretax Income | -1.55M |
Net Income | -1.55M |
EBITDA | -1.29M |
EBIT | -1.33M |
Earnings Per Share (EPS) | -0.02 |
Balance Sheet
The company has 48,000 in cash and 4.23 million in debt, giving a net cash position of -4.19 million or -0.05 per share.
Cash & Cash Equivalents | 48,000 |
Total Debt | 4.23M |
Net Cash | -4.19M |
Net Cash Per Share | -0.05 |
Equity (Book Value) | -7.36M |
Book Value Per Share | -0.09 |
Working Capital | -7.52M |
Cash Flow
Operating Cash Flow | -153,000 |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
ChitogenX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -43.11% |
Shareholder Yield | -43.11% |
Earnings Yield | -118.82% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |